Ligand Pharmaceuticals
LGND
LGND
275 hedge funds and large institutions have $2.32B invested in Ligand Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 75 increasing their positions, 130 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
58% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 50
82% less call options, than puts
Call options by funds: $36.6M | Put options by funds: $200M
Holders
275
Holding in Top 10
2
Calls
$36.6M
Puts
$200M
Top Buyers
| 1 | +$43.7M | |
| 2 | +$15.9M | |
| 3 | +$14.8M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$13.5M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$10M |
Top Sellers
| 1 | -$33.6M | |
| 2 | -$20.9M | |
| 3 | -$20.3M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$17.8M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$17.2M |